Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Post-operative Endophthalmitis in a UK Region in the last 15 years

Ahmed Shalaby; Anastasios Sepetis; Sandro Di Simplicio; Alastair Lockwood

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5785. doi:

Glaucoma July 2017

An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring

PDF

Abeer H. A. Mohamed-Ahmed; Alastair Lockwood; He Li; Maryse Bailly; Peng T. Khaw; Steve Brocchini
TAGS: cicatrix, eyedrops, solubility, water, painful bladder syndrome, mass or substance concentration per volume, body tissue, conjunctiva, body fluid
Invest. Ophthalmol. Vis. Sci.. 2017; 58(9):3425-3431. doi: https://doi.org/10.1167/iovs.16-21377

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2017

A UK survey of anti-VEGF use for the eye in January 2015

Sandro Di Simplicio; Ahmed Shalaby; Karinya Lewis; Kate Bush; Paul Meredith; Alastair Lockwood

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):868. doi:

ARVO Annual Meeting Abstract April 2014

An in vitro model to determine therapeutic protein pharmacokinetics

Sahar Awwad; Alastair Lockwood; Steve Brocchini; Peng Khaw

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5255. doi:

ARVO Annual Meeting Abstract April 2014

Bivalent anti-TNF-α Fab-PEG-Fab for ocular inflammation

Hanieh Khalili; Ashkan Khalili; Garima Sharma; Alastair Lockwood; Peng Khaw; Steve Brocchini

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6298. doi:

ARVO Annual Meeting Abstract April 2014

in vivo imaging of MMP-2 expression in the conjunctiva following implantation of Ilomastat or ethylcellulose tissue-tablet

Ashkan Khalili; Garima Sharma; Hanieh Khalili; Gavin Bennett; Alastair Lockwood; Steve Brocchini; Peng Khaw

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3201. doi:

ARVO Annual Meeting Abstract April 2014

An ethylcellulose spacer is similar to mitomycin C in prolonging bleb survival in an experimental animal model

Alastair Lockwood; Abeer Mohamed Ahmed; Ashkan Khalili; Sahar Awwad; Garima Sharma; Athmar Dhahir Habeeb; Hanieh Khalili; Steve Brocchini; Peng Khaw

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3202. doi:

ARVO Annual Meeting Abstract April 2014

Co-culture of Human Tenon Fibroblast and macrophages as a novel in-vitro model for conjunctival scarring

Garima Sharma; Hanieh Khalili; He Li; Ashkan Khalili; Alastair Lockwood; Derek Gilroy; Steve Brocchini; Peng Khaw; Maryse Bailly

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3203. doi:

ARVO Annual Meeting Abstract April 2014

Developing phosphotidyl choline polymers for ocular implantation

Athmar Dhahir Habeeb; Alastair Lockwood; Ali A Hussain; Jin H Wang; Mike Driver; Steve Brocchini; Peng Khaw

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):477. doi:

ARVO Annual Meeting Abstract June 2013

Hyaluronic acid based tablet for slow release of ilomastat in glaucoma filtration surgery

Abeer Mohamed Ahmed; Alastair Lockwood; Steve Brocchini; Peng Khaw

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1075. doi:

ARVO Annual Meeting Abstract June 2013

Proteins in solid dosage form (implantable tablets) for ocular delivery

Ashkan Khalili; Garima Sharma; Alastair Lockwood; Sahar Awwad; Steve Brocchini; Peng Khaw

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1088. doi:

ARVO Annual Meeting Abstract June 2013

The effect of steroid and matrix metalloproteinase inhibitor on bleb survival in an experimental animal model

Alastair Lockwood; Abeer Mohamed Ahmed; Ashkan Khalili; Sahar Awwad; Garima Sharma; Steve Brocchini; Peng Khaw

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4480. doi:

ARVO Annual Meeting Abstract June 2013

Development of an in vitro pharmacokinetic model of the human eye

Sahar Awwad; Alastair Lockwood; Abeer Mohamed Ahmed; Garima Sharma; Ashkan Khalili; Steve Brocchini; Peng Khaw

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5068. doi:

ARVO Annual Meeting Abstract March 2012

Evaluation Of Blood Vessel Leakage By Angiography After Experimental Model Of Glaucoma Filtration Surgery

Ashkan Khalili; Suryanarayana Rayapureddi; Sauparnika Vijay; Alastair Lockwood; Hala M. Fadda; Pallavi Purohit; Sarfaraj Topia; Steve Brocchini; Peng T. Khaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2511. doi:

ARVO Annual Meeting Abstract March 2012

The Effect Of A Water Soluble Matrix Metalloproteinase Inhibitor On Prolonging Bleb Survival In An Experimental Animal Model

Alastair Lockwood; Abeer Mohamed Ahmed; Ashkan Khalili; Garima Sharma; Sahar Awwad; Steve Brocchini; Peng T. Khaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2519. doi:

ARVO Annual Meeting Abstract March 2012

Cellulose Based Tablet For Sustained Release Of Ilomastat

Abeer Mohamed Ahmed; Alastair Lockwood; Sahar Awwad; Garima Sharma; Peng T. Khaw; Steve Brocchini

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):502. doi:

ARVO Annual Meeting Abstract April 2011

The Effect Of Gamma Irradiation On The Physicochemical Properties Of A Matrix Metalloproteinase Inhibitor Ilomastat: A Multi-supplier Consistency Study

Anja Vetter; Alastair Lockwood; Hala Fadda; Simon Gaisford; Peng T. Khaw; Stephen Brocchini

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3232. doi:

ARVO Annual Meeting Abstract April 2011

A Single Application Sustained Release Matrix Metalloproteinase Inhibitor At A Low Dose Is Superior To Mitomycin C In Prolonging Bleb Survival

Alastair Lockwood; Sumit Dhingra; Hala Fadda; Anja Vetter; Ashkan Khalili; Steve Brocchini; Peng T. Khaw

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):616. doi:

ARVO Annual Meeting Abstract April 2011

A Novel Slow Release Solid Bevacizumab Tissue Tablet Prevents Scarring Following Experimental Glaucoma Filtration Surgery (GFS)

Ashkan Khalili; Suryanarayana Rayapureddi; Daniel J. Paull; Hala M. Fadda; Alastair Lockwood; James S. Ellis; Steve Brocchini; Peng T. Khaw

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1645. doi:

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Post-operative Endophthalmitis in a UK Region in the last 15 years

An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring

A UK survey of anti-VEGF use for the eye in January 2015

An in vitro model to determine therapeutic protein pharmacokinetics

Bivalent anti-TNF-α Fab-PEG-Fab for ocular inflammation

in vivo imaging of MMP-2 expression in the conjunctiva following implantation of Ilomastat or ethylcellulose tissue-tablet

An ethylcellulose spacer is similar to mitomycin C in prolonging bleb survival in an experimental animal model

Co-culture of Human Tenon Fibroblast and macrophages as a novel in-vitro model for conjunctival scarring

Developing phosphotidyl choline polymers for ocular implantation

Hyaluronic acid based tablet for slow release of ilomastat in glaucoma filtration surgery

Proteins in solid dosage form (implantable tablets) for ocular delivery

The effect of steroid and matrix metalloproteinase inhibitor on bleb survival in an experimental animal model

Development of an in vitro pharmacokinetic model of the human eye

Evaluation Of Blood Vessel Leakage By Angiography After Experimental Model Of Glaucoma Filtration Surgery

The Effect Of A Water Soluble Matrix Metalloproteinase Inhibitor On Prolonging Bleb Survival In An Experimental Animal Model

Cellulose Based Tablet For Sustained Release Of Ilomastat

The Effect Of Gamma Irradiation On The Physicochemical Properties Of A Matrix Metalloproteinase Inhibitor Ilomastat: A Multi-supplier Consistency Study

A Single Application Sustained Release Matrix Metalloproteinase Inhibitor At A Low Dose Is Superior To Mitomycin C In Prolonging Bleb Survival

A Novel Slow Release Solid Bevacizumab Tissue Tablet Prevents Scarring Following Experimental Glaucoma Filtration Surgery (GFS)

To View More...

You must be signed into an individual account to use this feature.